Anan zaku iya samun jerin manyan kamfanonin fasahar kere-kere a duniya dangane da Jimillar Harajin Kuɗi.
Amgen Inc shine kamfanin fasahar kere kere na duniya na 1 a duniya tare da kudaden shiga na dala biliyan 25 daga Amurka sannan kuma Gilead Sciences, Inc.
Jerin Manyan Kamfanonin Biotech Na Duniya
Anan ne manyan kamfanonin fasahar kere-kere a duniya waɗanda aka ware su bisa jimillar Kuɗaɗen Kuɗi. jerin kamfanonin fasahar kere kere a duniya.
| S.No | Company Name | Jimlar Kuɗi | Kasa |
| 1 | Amgen Inc | $ 25 biliyan | Amurka |
| 2 | Garantin Sciences, Inc. | $ 25 biliyan | Amurka |
| 3 | Kamfanin Biogen Inc. | $ 12 biliyan | Amurka |
| 4 | CSL LTD | $ 10 biliyan | Australia |
| 5 | Abubuwan da aka bayar na Regeneron Pharmaceuticals, Inc. | $ 8 biliyan | Amurka |
| 6 | Magungunan Vertex Ba a haɗa su ba | $ 6 biliyan | Amurka |
| 7 | SHN NEPTUNUS BIO | $ 6 biliyan | Sin |
| 8 | LONZA N | $ 5 biliyan | Switzerland |
| 9 | SINO BIOPHARMACEUTICAL | $ 3 biliyan | Hong Kong |
| 10 | Illumina, Inc. | $ 3 biliyan | Amurka |
| 11 | Kamfanin Incyte | $ 3 biliyan | Amurka |
| 12 | Abubuwan da aka bayar na LIAONING CHENGDA CO., LTD. | $ 3 biliyan | Sin |
| 13 | Kamfanin SICHUAN KELUN PHAR | $ 2 biliyan | Sin |
| 14 | NOVOZYMES BA/S | $ 2 biliyan | Denmark |
| 15 | Seagen Inc. girma | $ 2 biliyan | Amurka |
| 16 | Kamfanin Swedish Orphan BIOVITRUM AB | $ 2 biliyan | Sweden |
| 17 | BioMarin Pharmaceutical Inc. girma | $ 2 biliyan | Amurka |
| 18 | CELLTRION | $ 2 biliyan | Koriya ta Kudu |
| 19 | Daidai Sciences Corporation | $ 1 biliyan | Amurka |
| 20 | CHANGCHUN BABBAN SABO | $ 1 biliyan | Sin |
| 21 | Abubuwan da aka bayar na BGI GENOMICS CO | $ 1 biliyan | Sin |
| 22 | CHR. Kudin hannun jari HANSEN HOLDING A/S | $ 1 biliyan | Denmark |
| 23 | SAMSUNG BIOLOGICS | $ 1 biliyan | Koriya ta Kudu |
| 24 | Abubuwan da aka bayar na FUJIAN ANJOY FOODS CO., LTD | $ 1 biliyan | Sin |
| 25 | Neurocrine Biosciences, Inc. girma | $ 1 biliyan | Amurka |
| 26 | Alkermes plc girma | $ 1 biliyan | Ireland |
| 27 | SEEGNE | $ 1 biliyan | Koriya ta Kudu |
Don haka waɗannan su ne manyan kamfanonin fasahar kere-kere a duniya bisa girmansu.
Amgen - Kamfanin Biotech mafi girma a duniya
Amgen yana daya daga cikin manyan kamfanonin fasahar kere-kere a duniya. Amgen kamfani ne na tushen ƙima, mai tushe mai zurfi a cikin kimiyya da ƙima don canza sabbin dabaru da bincike zuwa magunguna ga marasa lafiya da manyan cututtuka.
Kamfanin yana kasancewa a cikin kasashe da yankuna kusan 100 a duniya kuma sabbin magunguna sun kai miliyoyin mutane a cikin yaƙi da cututtuka masu tsanani. Kamfanin Biotech yana mai da hankali kan wuraren warkewa guda shida: cututtukan zuciya, cututtukan daji, lafiyar kasusuwa, neuroscience, nephrology da kumburi. Magungunan kamfanin yawanci suna magance cututtuka waɗanda ke da iyakacin zaɓuɓɓukan magani, ko kuma magunguna ne waɗanda ke ba da zaɓi mai dacewa ga abin da ke akwai.
Kimiyya ta Gilead
Gilead Sciences, Inc. tarihin farashikamfanin harhada magunguna wanda ya bi kuma ya sami ci gaba a fannin likitanci fiye da shekaru talatin, tare da burin samar da ingantacciyar duniya ga dukkan mutane.
Kamfanin ya himmatu wajen haɓaka sabbin magunguna don rigakafi da magance cututtukan da ke barazana ga rayuwa, gami da HIV, hepatitis viral da kansa. Gileyad tana aiki a cikin ƙasashe sama da 35 a duk duniya, tare da hedkwata a Foster City, California.
Kamfanin Biogen Inc.
Daya daga cikin kamfanonin fasahar kere-kere na farko a duniya, Biogen an kafa shi ne a shekarar 1978 ta Charles Weissmann, da Heinz Schaller, da Sir Kenneth Murray, da wadanda suka lashe kyautar Nobel Walter Gilbert da Phillip Sharp.
A yau, Biogen yana da babban fayil ɗin magunguna don magance sclerosis mai yawa, ya gabatar da magani na farko da aka amince da shi don ciwon ƙwayar tsoka na kashin baya, kuma ya haɓaka magani na farko kuma kawai wanda aka yarda da shi don magance ƙayyadaddun cututtukan cututtukan Alzheimer.
Biogen kuma yana tallata simintin halittu tare da mai da hankali kan haɓaka ɗayan manyan bututun masana'antu a cikin ilimin jijiya wanda zai canza matsayin kulawa ga marasa lafiya a wurare da yawa na buƙatu masu yawa.
A cikin 2020, Biogen ya ƙaddamar da wani yunƙuri na shekaru 20, dala miliyan 250 don magance matsalolin da ke da alaƙa mai zurfi na yanayi, lafiya, da daidaito. Lafiyayyan Yanayi, Lafiyayyen Rayuwa ™ yana nufin kawar da burbushin mai a duk faɗin ayyukan kamfanin, gina haɗin gwiwa tare da mashahuran cibiyoyi don haɓaka kimiyya don haɓaka sakamakon lafiyar ɗan adam, da tallafawa al'ummomin da ba a kula da su ba.
